|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/12 | |
| A61K 47/28 | |||
| A61K 47/34 | |||
| A61K 9/107 | |||
| A61K 9/51 | |||
| A61K 31/5377 |
| (11) | Number of the document | 3511019 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19156064.8 |
| Date of filing the European patent application | 2015-03-13 | |
| (97) | Date of publication of the European application | 2019-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461953628 P | 2014-03-14 | US |
| (72) |
BAGRODIA, Shubha, US
LAFONTAINE, Jennifer, US
LOVATT, Zach, US
SHIN, Eyoung, US
SONG, Young, Ho, US
TROIANO, Greg, US
WANG, Hong, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME |
| THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME |